| Date Filed | Type | Description |
| 10/12/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/16/2023 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 7.6% stake in ZURA BIO LIMITED |
| 04/13/2023 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.4% stake in HERON THERAPEUTICS, INC. |
| 02/27/2023 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 7.3% stake in Precision BioSciences Inc. |
| 02/14/2023 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 10% stake in OPTINOSE, INC. |
| 02/14/2023 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 3.1% stake in Kalvista Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 1.4% stake in 89bio, Inc. |
| 02/14/2023 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 3.4% stake in Precision BioSciences Inc. |
| 02/14/2023 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 7.9% stake in ALPINE IMMUNE SCIENCES, INC. |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/01/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 09/30/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/01/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/18/2022 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.2% stake in Kalvista Pharmaceuticals, Inc. |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in InflaRx N.V. |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/17/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 03/08/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/16/2021 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in TG Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in Abeona Therapeutics Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 4% stake in Geron Corporation |
| 02/16/2021 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 1.4% stake in Millendo Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 1.8% stake in Zymeworks Inc. |
|